Bodyfriend, 34.6% Increase in Operating Profit in 2024 Compared to Previous Year

Sales Reach 436.8 Billion KRW... Up 4.1%

Healthcare robot company Bodyfriend succeeded in reversing its performance last year with simultaneous increases in sales and operating profit.

On the 31st, Bodyfriend announced that its operating profit (consolidated basis) for 2024 increased by 34.6% compared to the same period last year, reaching 22.5 billion KRW. During the same period, sales rose by 4.1% to 436.8 billion KRW. A Bodyfriend representative analyzed, "The biggest factor behind the performance rebound is securing innovative technology through continuous research and development (R&D) investment and launching new healthcare robot products applying this technology."

Bodyfriend's R&D expenses last year amounted to 20 billion KRW, accounting for 4.5% of sales. As a result of active investment, Bodyfriend introduced the purely domestic technology called 'Robotics Technology.' Healthcare robots based on Robotics Technology refer to a product line that uses robotic technology to induce various movements throughout the body, deeply and precisely stimulating muscles and providing core exercises. Last year, the company aggressively launched new products such as the healthcare robots Eden and Pharaoh Neo, as well as the medical device Medical Pharaoh, which combines Robotics Technology.

A Bodyfriend representative said, "Despite the global economic downturn and severe domestic demand slump last year, our company continued R&D investment and succeeded in reversing performance by leveraging the technological competitiveness of healthcare robots," adding, "Building on last year's performance rebound, we plan to achieve meaningful results this year by further increasing market share in the healthcare sector and expanding our product portfolio as a furniture brand to gain consumers' choice."

This content was produced with the assistance of AI translation services.